Kocot-Kępska, M.; Zajączkowska, R.; Mika, J.; Kopsky, D.J.; Wordliczek, J.; Dobrogowski, J.; Przeklasa-Muszyńska, A.
Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain—Narrative Review. Pharmaceutics 2021, 13, 450.
https://doi.org/10.3390/pharmaceutics13040450
AMA Style
Kocot-Kępska M, Zajączkowska R, Mika J, Kopsky DJ, Wordliczek J, Dobrogowski J, Przeklasa-Muszyńska A.
Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain—Narrative Review. Pharmaceutics. 2021; 13(4):450.
https://doi.org/10.3390/pharmaceutics13040450
Chicago/Turabian Style
Kocot-Kępska, Magdalena, Renata Zajączkowska, Joanna Mika, David J. Kopsky, Jerzy Wordliczek, Jan Dobrogowski, and Anna Przeklasa-Muszyńska.
2021. "Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain—Narrative Review" Pharmaceutics 13, no. 4: 450.
https://doi.org/10.3390/pharmaceutics13040450
APA Style
Kocot-Kępska, M., Zajączkowska, R., Mika, J., Kopsky, D. J., Wordliczek, J., Dobrogowski, J., & Przeklasa-Muszyńska, A.
(2021). Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain—Narrative Review. Pharmaceutics, 13(4), 450.
https://doi.org/10.3390/pharmaceutics13040450